Cargando…
Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study
BACKGROUND: Mineralocorticoid receptor antagonists (MRA) are an underutilized therapy for heart failure with a reduced ejection fraction (HFrEF), but the current impact of hospitalization on MRA use is not well characterized. The objective of this study was to describe contemporary MRA prescription...
Autores principales: | Durstenfeld, Matthew S., Katz, Stuart D., Park, Hannah, Blecker, Saul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688376/ https://www.ncbi.nlm.nih.gov/pubmed/31399059 http://dx.doi.org/10.1186/s12872-019-1175-3 |
Ejemplares similares
-
Temporal Trends and Hospital Variation in Mineralocorticoid Receptor Antagonist Use in Veterans Discharged With Heart Failure
por: Dev, Sandesh, et al.
Publicado: (2015) -
Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes
por: Blecker, Saul, et al.
Publicado: (2016) -
Mineralocorticoid receptor antagonist use following heart failure hospitalization
por: Duran, Jason M., et al.
Publicado: (2020) -
Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade
por: Jadhav, Uday, et al.
Publicado: (2023) -
Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
por: Berbenetz, Nicolas M., et al.
Publicado: (2016)